NCT07066969View on ClinicalTrials.gov

Prevalence of Germline Alterations in Actionable Genes in Endometrial Cancer

NANot yet recruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions

Endometrial Cancer

Interventions

GENETIC

Sophia DDM

Germline panel for patients with tumoral BRCA alteration in EC

Trial Locations (1)

20141

European Institute of Oncology, Milan

All Listed Sponsors

lead

European Institute of Oncology

OTHER